MedTrace Logo

TSPO PET in the Evaluation of Neuroinflammation in Patients with Multiple System Atrophy

NCT06890390 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 90

Last updated 2025-03-24

No results posted yet for this study

Summary

The aim of this study was to apply PET/MR techniques targeting TSPO to explore the temporal and spatial alterations characterizing neuroinflammation in MSA patients, and to assess its value as a biomarker for diagnostic typing, disease severity, and prognosis of MSA disease.

Conditions

  • Multiple System Atrophy - Cerebellar Subtype (MSA-C)
  • Multiple System Atrophy - Parkinsonian Subtype (MSA-P)

Sponsors & Collaborators

  • Min Zhao,MD

    lead OTHER

Eligibility

Min Age
35 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2024-09-14
Primary Completion
2026-03-31
Completion
2026-03-31

Countries

  • China

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06890390 on ClinicalTrials.gov